NCT07766551

Brief Summary

Coronary artery disease (CAD) affects an estimated 11.39 million people in China, and mortality has continued to rise since 2012. Quality-of-care data indicate persistent gaps in diagnostic and therapeutic guideline adherence, incomplete implementation of secondary prevention, and suboptimal risk-factor control. Large language models (LLMs) can rapidly retrieve and integrate literature, medical records, and multimodal clinical data, and may support clinical decision-making. However, most existing medical LLMs are general-purpose, are trained predominantly on published literature and web text rather than authentic clinical records, and have not been validated with real patient data. No disease-specific LLM for CAD currently exists, and no evaluation framework tailored to CAD has been established; existing benchmarks are general-purpose, lack specialty-specific risk grading, are not rigorously anchored to current guidelines, and emphasize literal accuracy over clinically critical reasoning steps and prescription concordance. This prospective, multicenter, observational study will enroll approximately 640 patients with confirmed or suspected CAD at Fuwai Hospital and collaborating centers. No study-specific intervention, examination, biospecimen collection, or additional follow-up visit is performed; all clinical decisions are made independently by the treating physician according to routine standards of care. For consenting participants, routinely generated clinical documentation from the index outpatient visit or hospitalization - including medical history, laboratory results, imaging and coronary angiography/coronary CT angiography reports, physician notes, online consultation records, and follow-up records - will be de-identified and used to construct a high-quality multimodal CAD dataset. This dataset will support the development of a CAD-specific large language model (CorAI), the construction of an evaluation framework spanning eight predefined clinical scenarios and multiple assessment dimensions, and external validation of the model at participating centers. The primary objectives are to characterize the completeness and quality of the constructed prospective cohort dataset, and to quantify the guideline concordance of CorAI-generated clinical recommendations as adjudicated by a blinded panel of cardiologists.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
640

participants targeted

Target at P75+ for all trials

Timeline
13mo left

Started Aug 2026

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

August 17, 2026

Expected
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 11, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Artificial IntelligenceLarge Language ModelsCoronary Heart Disease (CHD)

Outcome Measures

Primary Outcomes (1)

  • Completeness of the constructed multimodal CAD dataset

    Proportion of enrolled participants whose de-identified record satisfies all pre-specified data-completeness criteria, defined as the presence of medical history, comorbidity and medication documentation, laboratory results, electrocardiography, coronary CT angiography and/or invasive coronary angiography findings, and at least one structured follow-up or discharge record sufficient to reconstruct a complete clinical scenario. Reported as a percentage with 95% confidence interval.

    From enrollment of the first participant through completion of dataset construction, up to 12 months

Secondary Outcomes (1)

  • Guideline concordance of CorAI-generated clinical recommendations across eight predefined coronary artery disease scenarios

    At completion of model development and evaluation, up to 18 months

Study Arms (1)

CorAI development and evaluation cohort

Adults aged 18 years or older with confirmed or suspected coronary artery disease presenting for routine outpatient or inpatient care at a participating center. Routinely generated clinical documentation is de-identified and used for construction of a multimodal CAD dataset and for development and evaluation of a disease-specific large language model. No study-specific intervention, testing, or follow-up is performed.

Other: No Intervention: Observational Cohort

Interventions

No Intervention: Observational Cohort

CorAI development and evaluation cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with confirmed or suspected coronary heart disease.

You may qualify if:

  • Age ≥ 18 years;
  • Patients with confirmed or suspected coronary heart disease;
  • Complete case information (including medical history, test results, imaging, follow-up records, etc.);
  • Consent for the use of case data for model evaluation and research analysis.

You may not qualify if:

  • Cases with severe data gaps that prevent the formation of a complete clinical scenario;
  • Cases where the primary diagnosis is not coronary heart disease;
  • Cases with serious data errors or where data cannot be anonymized.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

The First Affiliated Hospital of USTC

Hefei, Anhui, 230001, China

Location

Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, 100037, China

Location

Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen

Shenzhen, Guangdong, 518057, China

Location

MeSH Terms

Conditions

Coronary Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 14, 2026

Study Start (Estimated)

August 17, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

August 14, 2026

Record last verified: 2026-08

Locations